Matches in SemOpenAlex for { <https://semopenalex.org/work/W91875209> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W91875209 endingPage "31" @default.
- W91875209 startingPage "2826" @default.
- W91875209 abstract "Iloprost has been used to test acute pulmonary vasoreactivity in idiopathic pulmonary arterial hypertension (PAH). We aimed to investigate the acute hemodynamic and oxygenation responses and tolerability to 20 µg aerosolized Iloprost in Chinese patients with pulmonary hypertension.Between March 2005 and May 2010, 212 pulmonary hypertension patients inhaled a single dose of 20 µg Iloprost over 10 - 15 minutes for vasoreactivity testing. The acute hemodynamic and oxygenation responses and adverse events were recorded.Iloprost decreased total pulmonary resistance ((1747 ± 918) dyn×s×cm(-5) vs. (1581 ± 937) dyn×s×cm(-5), P < 0.001), increased stroke volume ((45.0 ± 22.1) ml vs. (47.0 ± 24.2) ml, P = 0.002), and cardiac output ((3.7 ± 1.7) L/ml vs. (3.9 ± 1.9) L/min, P = 0.009). Heart rate and systemic vascular resistance remained stable during inhalation. However, systemic arterial blood oxygen saturation fell slightly ((91.0 ± 6.8)% vs. (90.3 ± 6.7)%, P = 0.002). Pulmonary and systemic arterial blood pressures declined within 1 - 3 minutes after inhalation initiation and reached their lowest levels within 10 - 15 minutes. Idiopathic PAH responded more favorably than pulmonary hypertension due to other causes (P £0.001) and patients with less severe pulmonary hypertension have better responses to Iloprost. No adverse events requiring medical care or leading to termination of inhalation occurred.Inhalation of 20 µg Iloprost showed potent and selective pulmonary hemodynamic effects and was well tolerated in the Chinese pulmonary hypertension patients. Patients with idiopathic PAH and less severe pulmonary hypertension responded more favorably to inhalation of Iloprost." @default.
- W91875209 created "2016-06-24" @default.
- W91875209 creator A5007054845 @default.
- W91875209 creator A5020377193 @default.
- W91875209 creator A5034016457 @default.
- W91875209 creator A5048730835 @default.
- W91875209 creator A5055080226 @default.
- W91875209 creator A5065645774 @default.
- W91875209 creator A5069887443 @default.
- W91875209 creator A5077067762 @default.
- W91875209 creator A5077391806 @default.
- W91875209 creator A5088891531 @default.
- W91875209 date "2012-08-01" @default.
- W91875209 modified "2023-09-26" @default.
- W91875209 title "Acute responses to inhalation of Iloprost in patients with pulmonary hypertension." @default.
- W91875209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22932074" @default.
- W91875209 hasPublicationYear "2012" @default.
- W91875209 type Work @default.
- W91875209 sameAs 91875209 @default.
- W91875209 citedByCount "10" @default.
- W91875209 countsByYear W918752092014 @default.
- W91875209 countsByYear W918752092015 @default.
- W91875209 countsByYear W918752092017 @default.
- W91875209 countsByYear W918752092020 @default.
- W91875209 countsByYear W918752092021 @default.
- W91875209 countsByYear W918752092022 @default.
- W91875209 crossrefType "journal-article" @default.
- W91875209 hasAuthorship W91875209A5007054845 @default.
- W91875209 hasAuthorship W91875209A5020377193 @default.
- W91875209 hasAuthorship W91875209A5034016457 @default.
- W91875209 hasAuthorship W91875209A5048730835 @default.
- W91875209 hasAuthorship W91875209A5055080226 @default.
- W91875209 hasAuthorship W91875209A5065645774 @default.
- W91875209 hasAuthorship W91875209A5069887443 @default.
- W91875209 hasAuthorship W91875209A5077067762 @default.
- W91875209 hasAuthorship W91875209A5077391806 @default.
- W91875209 hasAuthorship W91875209A5088891531 @default.
- W91875209 hasConcept C126322002 @default.
- W91875209 hasConcept C139940330 @default.
- W91875209 hasConcept C164705383 @default.
- W91875209 hasConcept C178853913 @default.
- W91875209 hasConcept C197934379 @default.
- W91875209 hasConcept C2776954882 @default.
- W91875209 hasConcept C2778375690 @default.
- W91875209 hasConcept C2780930700 @default.
- W91875209 hasConcept C2781103887 @default.
- W91875209 hasConcept C2781128415 @default.
- W91875209 hasConcept C29323129 @default.
- W91875209 hasConcept C42219234 @default.
- W91875209 hasConcept C58245268 @default.
- W91875209 hasConcept C70289976 @default.
- W91875209 hasConcept C71924100 @default.
- W91875209 hasConceptScore W91875209C126322002 @default.
- W91875209 hasConceptScore W91875209C139940330 @default.
- W91875209 hasConceptScore W91875209C164705383 @default.
- W91875209 hasConceptScore W91875209C178853913 @default.
- W91875209 hasConceptScore W91875209C197934379 @default.
- W91875209 hasConceptScore W91875209C2776954882 @default.
- W91875209 hasConceptScore W91875209C2778375690 @default.
- W91875209 hasConceptScore W91875209C2780930700 @default.
- W91875209 hasConceptScore W91875209C2781103887 @default.
- W91875209 hasConceptScore W91875209C2781128415 @default.
- W91875209 hasConceptScore W91875209C29323129 @default.
- W91875209 hasConceptScore W91875209C42219234 @default.
- W91875209 hasConceptScore W91875209C58245268 @default.
- W91875209 hasConceptScore W91875209C70289976 @default.
- W91875209 hasConceptScore W91875209C71924100 @default.
- W91875209 hasIssue "16" @default.
- W91875209 hasLocation W918752091 @default.
- W91875209 hasOpenAccess W91875209 @default.
- W91875209 hasPrimaryLocation W918752091 @default.
- W91875209 hasRelatedWork W1980067172 @default.
- W91875209 hasRelatedWork W1983217078 @default.
- W91875209 hasRelatedWork W1994993850 @default.
- W91875209 hasRelatedWork W2029590510 @default.
- W91875209 hasRelatedWork W2151411652 @default.
- W91875209 hasRelatedWork W2169245096 @default.
- W91875209 hasRelatedWork W2319686527 @default.
- W91875209 hasRelatedWork W2421433371 @default.
- W91875209 hasRelatedWork W91875209 @default.
- W91875209 hasRelatedWork W108069683 @default.
- W91875209 hasVolume "125" @default.
- W91875209 isParatext "false" @default.
- W91875209 isRetracted "false" @default.
- W91875209 magId "91875209" @default.
- W91875209 workType "article" @default.